[Takotsubo cardiomyopathy: a novel beta-adrenergic blocker withdrawal syndrome]

Orv Hetil. 2013 Feb 17;154(7):267-71. doi: 10.1556/OH.2013.29545.
[Article in Hungarian]

Abstract

The authors describe two cases of takotsubo cardiomyopathy developing after an abrupt withdrawal of carvedilol and bisoprolol. Takotsubo or stress cardiomyopathy is characterized by acute and reversible cardiac dysfunction without coronary artery disease. It is triggered by acute emotional or physical stress, drugs or drug withdrawal. The immediate discontinuation of the long acting vasodilator beta-blocker, carvedilol has not yet been described to cause takotsubo cardiomyopathy. The authors recommend cautious withdrawal of beta-blockers.

Publication types

  • Case Reports
  • English Abstract

MeSH terms

  • Adrenergic beta-1 Receptor Antagonists / administration & dosage
  • Adrenergic beta-1 Receptor Antagonists / adverse effects
  • Adrenergic beta-Antagonists / administration & dosage*
  • Adrenergic beta-Antagonists / adverse effects*
  • Aged
  • Angiotensin-Converting Enzyme Inhibitors / administration & dosage
  • Arrhythmias, Cardiac / chemically induced
  • Arrhythmias, Cardiac / drug therapy*
  • Bisoprolol / administration & dosage
  • Bisoprolol / adverse effects
  • Echocardiography
  • Electrocardiography
  • Female
  • Heart Conduction System / drug effects*
  • Heart Conduction System / physiopathology
  • Humans
  • Substance Withdrawal Syndrome / etiology*
  • Substance Withdrawal Syndrome / physiopathology
  • Takotsubo Cardiomyopathy / chemically induced*
  • Takotsubo Cardiomyopathy / physiopathology

Substances

  • Adrenergic beta-1 Receptor Antagonists
  • Adrenergic beta-Antagonists
  • Angiotensin-Converting Enzyme Inhibitors
  • Bisoprolol